# | Title | Journal | Year | Citations |
---|
1 | HFSA 2010 Comprehensive Heart Failure Practice Guideline | Journal of Cardiac Failure | 2010 | 1,086 |
2 | High Prevalence of Renal Dysfunction and Its Impact on Outcome in 118,465 Patients Hospitalized With Acute Decompensated Heart Failure: A Report From the ADHERE Database | Journal of Cardiac Failure | 2007 | 687 |
3 | Glucagon-Like Peptide-1 Infusion Improves Left Ventricular Ejection Fraction and Functional Status in Patients With Chronic Heart Failure | Journal of Cardiac Failure | 2006 | 572 |
4 | 2017 ACC/AHA/HFSA Focused Update of the 2013 ACCF/AHA Guideline for the Management of Heart Failure | Journal of Cardiac Failure | 2017 | 531 |
5 | Worsening Renal Function and Prognosis in Heart Failure: Systematic Review and Meta-Analysis | Journal of Cardiac Failure | 2007 | 527 |
6 | Genetic Evaluation of Cardiomyopathy—A Heart Failure Society of America Practice Guideline | Journal of Cardiac Failure | 2009 | 523 |
7 | The prognostic importance of different definitions of worsening renal function in congestive heart failure | Journal of Cardiac Failure | 2002 | 512 |
8 | Executive Summary: HFSA 2006 Comprehensive Heart Failure Practice Guideline | Journal of Cardiac Failure | 2006 | 491 |
9 | Racial differences in response to therapy for heart failure: Analysis of the vasodilator-heart failure trials | Journal of Cardiac Failure | 1999 | 467 |
10 | A rapid test for B-type natriuretic peptide correlates with falling wedge pressures in patients treated for decompensated heart failure: A pilot study | Journal of Cardiac Failure | 2001 | 404 |
11 | Basic mechanisms in heart failure: The cytokine hypothesis | Journal of Cardiac Failure | 1996 | 392 |
12 | Calcium Upregulation by Percutaneous Administration of Gene Therapy in Cardiac Disease (CUPID Trial), a First-in-Human Phase 1/2 Clinical Trial | Journal of Cardiac Failure | 2009 | 383 |
13 | Proposal for a new clinical end point to evaluate the efficacy of drugs and devices in the treatment of chronic heart failure | Journal of Cardiac Failure | 2001 | 366 |
14 | Universal Definition and Classification of Heart Failure | Journal of Cardiac Failure | 2021 | 362 |
15 | Validation and Potential Mechanisms of Red Cell Distribution Width as a Prognostic Marker in Heart Failure | Journal of Cardiac Failure | 2010 | 344 |
16 | The Journal of Cardiac Failure: Passing the Baton | Journal of Cardiac Failure | 2010 | 336 |
17 | The effects of simvastatin on the incidence of heart failure in patients with coronary heart disease | Journal of Cardiac Failure | 1997 | 334 |
18 | Consensus statement: palliative and supportive care in advanced heart failure | Journal of Cardiac Failure | 2004 | 321 |
19 | Joint HFSA/ACC/AHA Statement Addresses Concerns Re: Using RAAS Antagonists in COVID-19 | Journal of Cardiac Failure | 2020 | 312 |
20 | HFSA guidelines for management of patients with heart failure caused by left ventricular systolic dysfunction—pharmacological approaches | Journal of Cardiac Failure | 1999 | 306 |
21 | Low serum total cholesterol is associated with marked increase in mortality in advanced heart failure | Journal of Cardiac Failure | 2002 | 306 |
22 | Worsening renal function: What is a clinically meaningful change in creatinine during hospitalization with heart failure? | Journal of Cardiac Failure | 2003 | 304 |
23 | Heart failure management using implantable devices for ventricular resynchronization: Comparison of medical therapy, pacing, and defibrillation in chronic heart failure (COMPANION) trial | Journal of Cardiac Failure | 2000 | 299 |
24 | Psychometric testing of the self-care of heart failure index | Journal of Cardiac Failure | 2004 | 297 |
25 | Risk stratification after hospitalization for decompensated heart failure | Journal of Cardiac Failure | 2004 | 291 |
26 | Autonomic Regulation Therapy via Left or Right Cervical Vagus Nerve Stimulation in Patients With Chronic Heart Failure: Results of the ANTHEM-HF Trial | Journal of Cardiac Failure | 2014 | 289 |
27 | HFSA 2006 Comprehensive Heart Failure Practice Guideline: Introduction and Table of Contents | Journal of Cardiac Failure | 2006 | 288 |
28 | Advanced (Stage D) Heart Failure: A Statement From the Heart Failure Society of America Guidelines Committee | Journal of Cardiac Failure | 2015 | 283 |
29 | Body mass and survival in patients with chronic heart failure without cachexia: The importance of obesity | Journal of Cardiac Failure | 2003 | 281 |
30 | Genetic Evaluation of Cardiomyopathy—A Heart Failure Society of America Practice Guideline | Journal of Cardiac Failure | 2018 | 280 |
31 | The Effect of Alagebrium Chloride (ALT-711), a Novel Glucose Cross-Link Breaker, in the Treatment of Elderly Patients With Diastolic Heart Failure | Journal of Cardiac Failure | 2005 | 278 |
32 | Symptoms, Depression, and Quality of Life in Patients With Heart Failure | Journal of Cardiac Failure | 2007 | 277 |
33 | Intestinal Microbiota-Dependent Phosphatidylcholine Metabolites, Diastolic Dysfunction, and Adverse Clinical Outcomes in Chronic Systolic Heart Failure | Journal of Cardiac Failure | 2015 | 271 |
34 | Executive Summary: HFSA 2010 Comprehensive Heart Failure Practice Guideline | Journal of Cardiac Failure | 2010 | 267 |
35 | Candesartan in heart failure—assessment of reduction in mortality and morbidity (CHARM): Rationale and design | Journal of Cardiac Failure | 1999 | 260 |
36 | Cognitive Impairment and Heart Failure: Systematic Review and Meta-Analysis | Journal of Cardiac Failure | 2017 | 255 |
37 | Elevated Troponin in Patients With Coronavirus Disease 2019: Possible Mechanisms | Journal of Cardiac Failure | 2020 | 253 |
38 | Clinical effects of endothelin receptor antagonism with bosentan in patients with severe chronic heart failure: results of a pilot study | Journal of Cardiac Failure | 2005 | 250 |
39 | Clinical Features of Isolated Ventricular Noncompaction in Adults Long-Term Clinical Course, Echocardiographic Properties, and Predictors of Left Ventricular Failure | Journal of Cardiac Failure | 2006 | 244 |
40 | Hospitalization Epidemic in Patients With Heart Failure: Risk Factors, Risk Prediction, Knowledge Gaps, and Future Directions | Journal of Cardiac Failure | 2011 | 240 |
41 | Systemic hemodynamic, neurohormonal, and renal effects of a steady-state infusion of human brain natriuretic peptide in patients with hemodynamically decompensated heart failure | Journal of Cardiac Failure | 1998 | 233 |
42 | Demographics, Clinical Characteristics, and Outcomes of Patients Hospitalized for Decompensated Heart Failure: Observations From the IMPACT-HF Registry | Journal of Cardiac Failure | 2005 | 229 |
43 | Clinical Profile and Predictors of Complications in Peripartum Cardiomyopathy | Journal of Cardiac Failure | 2009 | 227 |
44 | Abnormal Liver Function in Relation to Hemodynamic Profile in Heart Failure Patients | Journal of Cardiac Failure | 2010 | 227 |
45 | Iron Deficiency Predicts Impaired Exercise Capacity in Patients With Systolic Chronic Heart Failure | Journal of Cardiac Failure | 2011 | 227 |
46 | Iron-Overload Cardiomyopathy: Pathophysiology, Diagnosis, and Treatment | Journal of Cardiac Failure | 2010 | 218 |
47 | Prevalence and Physiological Predictors of Sleep Apnea in Patients With Heart Failure and Systolic Dysfunction | Journal of Cardiac Failure | 2009 | 217 |
48 | Serum Neutrophil Gelatinase-Associated Lipocalin (NGAL) in Predicting Worsening Renal Function in Acute Decompensated Heart Failure | Journal of Cardiac Failure | 2010 | 217 |
49 | Care processes and clinical outcomes of continuous outpatient support with inotropes (COSI) in patients with refractory endstage heart failure | Journal of Cardiac Failure | 2003 | 216 |
50 | Prevalence, Morbidity, and Mortality of Heart Failure–Related Hospitalizations in Children in the United States: A Population-Based Study | Journal of Cardiac Failure | 2012 | 216 |